Drug intelligence / Profile preview

yiqing

Development stage
Unknown
Lead developer
Chengdu Kanghong Pharmaceutical
Administration
Oral
01

Overview

Yiqing is a Traditional Chinese Medicine (TCM) formulation derived from the classic "Sanhuang Xiexin Tang" decoction. It is primarily composed of extracts from three medicinal herbs: *Coptis chinensis* (Huanglian), *Scutellaria baicalensis* (Huangqin), and *Rheum palmatum* (Dahuang). The formula is traditionally used to clear heat, detoxify, and cool the blood to stop bleeding. Clinically, it is approved in China for treating conditions associated with "toxic heat" syndrome, such as acute pharyngitis, acute tonsillitis, gingivitis, and recurrent aphthous ulcers. Modern pharmacological research has demonstrated its anti-inflammatory, antibacterial, and antiviral properties, leading to clinical investigations for its efficacy in treating acne vulgaris and as an adjunctive therapy for COVID-19 (Omicron variant). It is manufactured in various forms, including capsules and oral liquids, by companies such as Chengdu Kanghong Pharmaceutical Group.

Brand names
Yiqing CapsuleYiqing Oral Liquid一清胶囊一清口服液
Other names
Yiqing一清
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on yiqing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiqing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call